Outcomes that need to be assessed in clinical trials for cutaneous neurofibromas in people with neurofibromatosis type 1. . Br J Dermatol 2024;190:e20.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Outcomes that need to be assessed in clinical trials for cutaneous neurofibromas in people with neurofibromatosis type 1. Br J Dermatol 2024;190:e20.
PMID: 38262593